×

EFFECTIVE TARGETING OF PRIMARY HUMAN LEUKEMIA USING ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR ENGINEERED T CELLS

  • US 20170183415A1
  • Filed: 01/06/2017
  • Published: 06/29/2017
  • Est. Priority Date: 02/20/2013
  • Status: Active Grant
First Claim
Patent Images

1-102. -102. (canceled)

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×